FrancophonIA/ELRC3.0 huggingface dataset:
English: 11l a Based upon Long Term Evaluation algorithm (LTE Analysis) - Patients who discontinued the study at any time prior to week 384 due to a protocol defined endpoint, as well as those completing week 384, are included in the denominator.
Danish: 11l a Baseret på Long Term Evaluation algoritme (LTE-analyse) - Patienter, som afbrød studiet på et vilkårligt tidspunkt før uge 384 pga. et protokoldefineret endepunkt, såvel som dem, der fuldførte uge 384, inkluderes i nævneren.
English: Look out for signs of inflammation or infection soon after you start taking Viread.
Danish: Hold øje med tegn på betændelse eller infektion i tiden lige efter, De begynder at tage Viread.
English: Mean change from baseline in CPT score Mean change from baseline in MELD score a p-value comparing the combined tenofovir-containing arms versus the entecavir arm = 0.622, b p-value comparing the combined tenofovir-containing arms versus the entecavir arm = 1.000.
Danish: Gennemsnitlig ændring fra baseline i CPT-score Gennemsnitlig ændring fra baseline i MELD-score a p-værdi ved sammenligning af de kombinerede tenofovirindeholdende arme versus entecavirarmen = 0,622, b p-værdi ved sammenligning af de kombinerede tenofovirindeholdende arme versus entecavirarmen = 1,000.
English: • Talk to your child's doctor before your child stops taking Viread for any reason, particularly if your child is experiencing any side effects or they have another illness.
Danish: • Tal med Deres barns læge, før Deres barn holder op med at tage Viread, uanset årsagen, især hvis Deres barn oplever bivirkninger eller har en anden sygdom.
English: The proportion of subjects with ALT normalization at week 192 in the tenofovir disoproxil-tenofovir disoproxil group was 75.8% (25/33) among those who were HBeAg positive at baseline and 100.0% (2 of 2 subjects) among those who were HBeAg negative at baseline.
Danish: Andelen af patienter med ALAT-normalisering ved uge 192 i tenofovirdisoproxil-tenofovirdisoproxil-gruppen var 75,8% (25/33) blandt de patienter, som var HBeAg-positive ved baseline, og 100,0% (2 af 2 patienter) blandt dem, der var HBeAg-negative ved baseline.
English: Confirmed increase in serum creatinine ≥ 0.5 mg/dl from baseline or confirmed serum phosphate of < 2 mg/dl n (%)b
Danish: Bekræftet forhøjelse af serumkreatinin ≥ 0,5 mg/dl fra baseline eller bekræftet serumphosphat på < 2 mg/dl n (%)b
English: The demonstration of benefit of tenofovir disoproxil in compensated and decompensated disease is based on virological, biochemical and serological responses in adults with HBeAg positive and HBeAg negative chronic hepatitis B. Treated patients included those who were treatment-naïve, lamivudine-experienced, adefovir dipivoxil-experienced and patients with lamivudine and/or adefovir dipivoxil resistance mutations at baseline.
Danish: Påvisningen af tenofovirdisoproxils gavnlige effekt på kompenseret og dekompenseret sygdom er baseret på virologisk, biokemisk og serologisk respons hos voksne med HBeAg-positiv og HBeAg-negativ kronisk hepatitis B. Behandlede patienter omfattede behandlingsnaive, lamivudinerfarne og adefovirdipivoxilerfarne patienter samt patienter med lamivudin- og/eller adefovirdipivoxilresistens-mutationer ved baseline.
English: High density polyethylene (HDPE) bottle with a polypropylene child-resistant closure containing 60 g of granules and a dosing scoop.
Danish: Højdensitets-polyethylen (HDPE)-beholder med børnesikret lukke af polypropylen indeholdende 60 g granulat og en måleske.
English: Viread is not usually taken with other medicines that can damage your child's kidneys (see Other medicines and Viread).
Danish: Viread tages normalt ikke sammen med anden medicin, som kan skade Deres barns nyrer (se Brug af anden medicin sammen med Viread).
English: • children and adolescents aged 2 to less than 18 years.
Danish: • børn og unge i alderen 2 til under 18 år.
English: Viread granules should be mixed in a container with soft food not requiring chewing, for example yoghurt, applesauce or baby food.
Danish: Viread granulat skal blandes i en beholder med blød mad, der ikke skal tygges, f.eks. yoghurt, æblemos eller babymad.
English: Therefore Viread should not be used during breast-feeding.
Danish: Viread bør derfor ikke anvendes under amning.
English: This dosing recommendation balances the need to limit drug accumulation while attempting to maintain sufficient tenofovir concentrations over the dosing interval similar to trough concentrations observed in patients with normal renal function receiving tenofovir disoproxil 245 mg film-coated tablets.
Danish: Denne dosisanbefaling afvejer behovet for at begrænse lægemiddelakkumulation og forsøget på at opretholde tilstrækkelige tenofovirkoncentrationer i doseringsintervallet, som er sammenlignelige med de dal-koncentrationer, der blev observeret hos patienter med normal nyrefunktion, der fik tenofovirdisoproxil 245 mg filmovertrukne tabletter.
English: Viread is not usually taken with other medicines that can damage your kidneys (see Other medicines and Viread).
Danish: Viread tages normalt ikke sammen med anden medicin, som kan skade Deres nyrer (se Brug af anden medicin sammen med Viread).
English: Table 7: Histological response (%) in compensated HBeAg negative and HBeAg positive subjects at week 240 compared to baseline
Danish: Tabel 7: Histologisk respons (%) hos kompenserede HBeAg-negative og HBeAg-positive forsøgspersoner ved uge 240 sammenlignet med baseline
English: Co-administration of other medicinal products - Viread should not be administered concomitantly with other medicinal products containing tenofovir disoproxil or tenofovir alafenamide.
Danish: Samtidig administration af andre lægemidler - Viread bør ikke tages samtidigt med andre lægemidler, der indeholder tenofovirdisoproxil eller tenofoviralafenamid.
English: Do not give Viread together with medicines containing adefovir dipivoxil (a medicine used to treat chronic hepatitis B).
Danish: Giv ikke Viread sammen med medicin, der indeholder adefovirdipivoxil (medicin, der anvendes til at behandle kronisk hepatitis B).
English: Among 28 patients receiving 96 weeks of treatment with tenofovir disoproxil, BMD Z-scores declined by -0.341 for lumbar spine and -0.458 for total body.
Danish: Blandt de 28 patienter, der blev behandlet i 96 uger med tenofovirdisoproxil, ændredes BMD Z-resultat med -0,341 for columna lumbalis og med -0,458 for hele kroppen.
English: Do not take Viread together with medicines containing adefovir dipivoxil (a medicine used to treat chronic hepatitis B).
Danish: Tag ikke Viread sammen med medicin, der indeholder adefovirdipivoxil (medicin, der anvendes til at behandle kronisk hepatitis B).
English: They are suitable for:
Danish: Det er egnet til:
English: One gram of granules contains 622 mg mannitol.
Danish: Hjælpestof, som behandleren skal være opmærksom på Et gram granulat indeholder 622 mg mannitol.
English: Other medicines and Viread
Danish: Brug af anden medicin sammen med Viread
English: Histology Histological response b
Danish: Histologi Histologisk respons (%)b
English: acute renal failure, renal failure, acute tubular necrosis, nephritis (including acute interstitial nephritis)2, nephrogenic diabetes insipidus General disorders and administration site conditions: Very common: asthenia
Danish: akut nyresvigt, nyresvigt, akut tubulær nekrose, nefritis (herunder akut interstitiel nefritis)2, nefrogen diabetes insipidus Almene symptomer og reaktioner på administrationssstedet: Meget almindelig: asteni
English: Administration of Viread 33 mg/g granules to provide a reduced daily dose of tenofovir disoproxil is recommended for adult patients with creatinine clearance < 50 ml/min, including haemodialysis patients.
Danish: Administration af Viread 33 mg/g granulat med henblik på at give en reduceret daglig dosis tenofovirdisoproxil anbefales til voksne patienter med kreatininclearance < 50 ml/min, herunder hos hæmodialysepatienter.
English: If you notice any of these symptoms tell your child's doctor.
Danish: Hvis De bemærker et eller flere af disse symptomer, skal De fortælle det til Deres barns læge.
English: ALT n (%)
Danish: ALAT n (%)
English: Croscarmellose sodium Lactose monohydrate Magnesium stearate (E572) Microcrystalline cellulose (E460) Starch pregelatinised
Danish: Croscarmellosenatrium Lactosemonohydrat Magnesiumstearat (E572) Mikrokrystallinsk cellulose (E460) Stivelse, prægelatineret
English: The antiviral response to tenofovir disoproxil was durable through 48 weeks (DAVG48 was -0.57 log10 copies/ml, proportion of patients with HIV-1 RNA below 400 or 50 copies/ml was 41% and 18% respectively).
Danish: Den antivirale respons over for tenofovirdisoproxil holdt sig i 48 uger (DAVG48 var -0,57 log10 kopier/ml, procentdelen af patienter med hiv 1-rna under 400 eller 50 kopier/ml var henholdsvis 41% og 18%).
English: If your child has hepatitis B infection, your child's doctor will carefully consider the best treatment for them.
Danish: Hvis Deres barn har en hepatitis B-infektion, vil Deres barns læge nøje overveje, hvilken behandling, der er den bedste for barnet.
English: Keep the granules bottle with you so that you can easily describe what you have taken.
Danish: Tag beholderen med granulatet med, så De let kan vise, hvad De har taget.
English: At week 168, in this population of patients with decompensated liver disease, the rate of death was of 13% (6/45) in the tenofovir disoproxil group, 11% (5/45) in the emtricitabine plus tenofovir disoproxil group and 14% (3/22) in the entecavir group.
Danish: Ved uge 168 var hyppigheden af dødsfald i denne population af patienter med dekompenseret leversygdom 13% (6/45) i tenofovirdisoproxil-gruppen, 11% (5/45) i emtricitabin plus tenofovirdisoproxil-gruppen og 14% (3/22) i entecavir-gruppen.
English: • Adults and adolescents aged 12 to less than 18 years and weighing at least 35 kg: 245 mg, equivalent to 7.5 scoops of granules, once a day.
Danish: Den anbefalede dosis er: • Voksne og unge i alderen 12 til under 18 år, som vejer mindst 35 kg: 245 mg, hvilket svarer til 7,5 måleskeer med granulat, en gang dagligt.
English: For dosage see section 3, How to take Viread.
Danish: 3, Sådan skal De tage Viread, for dosering.
English: Do not give a double dose to make up for a forgotten tablet.
Danish: De må ikke give en dobbeltdosis som erstatning for den glemte tablet.
English: • Your child must not breast-feed, to avoid passing the virus to the baby in breast milk.
Danish: • Deres barn må ikke amme for at undgå at smitte barnet via mælken.
English: Viread contains lactose
Danish: Viread indeholder laktose
English: INFORMATION IN BRAILLE Viread granules [Outer packaging only]
Danish: Viread granulat [kun på den ydre emballage]
English: 90 (3 bottles of 30) film-coated tablets.
Danish: 90 (3 tabletbeholdere med 30) filmovertrukne tabletter.
English: The results indicate that patients whose HIV expressed 3 or more thymidine-analogue associated mutations (TAMs) that included either the M41L or L210W reverse transcriptase mutation showed reduced response to tenofovir disoproxil 245 mg therapy.
Danish: Resultaterne indikerer, at patienter, hvis hiv udtrykte 3 eller flere thymidin-analog-forbundne mutationer (TAMs), som omfattede enten M41L- eller L210W-reverse transkriptase-mutation, viste reduceret respons over for behandlingen med 245 mg tenofovirdisoproxil .
English: Viruses containing the rtA181T mutation remained susceptible to tenofovir with EC50 values 1.5-fold that of wild-type virus.
Danish: Virus, som indeholdt rtA181Tmutationen, forblev følsomme over for tenofovir med EC50-værdier på 1,5 gange den for vildtypevirus.
English: HIV-1 and Chronic hepatitis B
Danish: Hiv-1 og kronisk hepatitis B
English: The rate of hepatocellular carcinoma was 18% (8/45) in the tenofovir disoproxil group, 7% (3/45) in the emtricitabine plus tenofovir disoproxil group and 9% (2/22) in the entecavir group.
Danish: Hyppigheden af hepatocellulært karcinom var 18% (8/45) i tenofovirdisoproxil-gruppen, 7% (3/45) i emtricitabin plus tenofovirdisoproxil-gruppen og 9% (2/22) i entecavir-gruppen.
English: All patients with normal ALT at baseline and 88% of patients with abnormal ALT at baseline achieved HBV DNA suppression < 400 copies/ml.
Danish: Alle patienter med normal ALAT ved baseline og 88% af patienterne med unormal ALAT ved baseline opnåede HBV-dna-suppression < 400 kopier/ml.
English: • adolescents aged 12 to less than 18 years.
Danish: • voksne • unge i alderen 12 til under 18 år.
English: A consistent response to treatment with tenofovir disoproxil 245 mg was seen regardless of baseline HIV-1 RNA and CD4 count.
Danish: En konsistent respons på behandling med 245 mg tenofovirdisoproxil sås uden hensyn til hiv 1-rna og CD4-tal ved baseline.
English: Both treatments produced similar results with regard to histological response (defined as Knodell necroinflammatory score improvement of at least 2 points without worsening in Knodell fibrosis) at week 48 (see Table 4 below).
Danish: Begge behandlinger producerede lignende resultater med hensyn til histologisk respons (defineret som en forbedring af Knodells nekroinflammatoriske score på mindst 2 point uden forværring af Knodells fibrosescore) ved uge 48 (se tabel 4 nedenfor).
English: At baseline, 57% of patients randomised to tenofovir disoproxil versus 60% of patients randomised to emtricitabine plus tenofovir disoproxil treatment group had previously been treated with lamivudine.
Danish: Ved baseline var 57% af de patienter, der var randomiseret til behandlingsgruppen med tenofovirdisoproxil versus 60% af de patienter, der var randomiseret til behandlingsgruppen med emtricitabin plus tenofovirdisoproxil, tidligere blevet behandlet med lamivudin.
English: • Don't stop any anti-HIV medicines prescribed by your doctor when you start Viread if you have both HBV and HIV.
Danish: • De skal fortsætte med at tage al Deres medicin mod hiv-infektion, som er ordineret af Deres læge, når De påbegynder behandlingen med Viread, hvis De har både HBV og hiv.
English: Administration of multiple doses of tenofovir disoproxil with a meal to HIV infected patients resulted in mean (%CV) tenofovir Cmax, AUC, and Cmin values of 326 (36.6%) ng/ml, 3,324 (41.2%) ng·h/ml and 64.4 (39.4%) ng/ml, respectively.
Danish: Administration af flere doser af tenofovirdisoproxil sammen med et måltid til hiv-inficerede patienter resulterede i gennemsnitlige værdier (% variationskoefficient) af tenofovir Cmax, AUC og Cmin på henholdsvis 326 (36,6%) ng/ml, 3.324 (41,2%) ng·t/ml og 64,4 (39,4%) ng/ml.
English: Serology (%) HBeAg loss/seroconversion n/a n/a
Danish: Serologi (%) Tab af HBeAg/serokonversion n/a n/a
English: In addition 55% (29/53) of patients treated with tenofovir disoproxil had undetectable HBV DNA (< 169 copies/ml [< 29 IU/ml]; the limit of quantification of the Roche Cobas TaqMan HBV assay) versus 60% (31/52) of patients treated with emtricitabine plus tenofovir disoproxil (p = 0.504).
Danish: Ydermere havde 55% (29/53) af patienterne behandlet med tenofovirdisoproxil HBV-dna, som ikke kunne måles (< 169 kopier/ml [< 29 IE/ml]; kvantificeringsgrænsen for Roche Cobas TaqMan HBV-analysen) versus 60% (31/52) af patienterne behandlet med emtricitabin plus tenofovirdisoproxil (p = 0,504).
English: A single 245 mg dose of tenofovir disoproxil was administered to non-HIV, non-HBV infected adult patients with varying degrees of hepatic impairment defined according to Child-Pugh-Turcotte (CPT) classification.
Danish: En enkelt dosis af 245 mg tenofovirdisoproxil blev administreret til voksne patienter uden hiv-infektion, uden HBV-infektion med forskellige grader af nedsat leverfunktion defineret i henhold til Child-Pugh-Turcotte (CPT) klassifikationen.
English: Refer to section 2 “Viread granules contain mannitol”.
Danish: 2 „Viread granulat indeholder mannitol“.
English: The recommended dose of Viread for the treatment of HIV or for the treatment of chronic hepatitis B is 245 mg, equivalent to 7.5 scoops of granules, once daily taken orally with food.
Danish: Den anbefalede dosis af Viread til behandling af hiv eller til behandling af kronisk hepatitis B er 245 mg, hvilket svarer til 7,5 måleskeer med granulat en gang dagligt taget oralt sammen med mad.
English: If your child forgets to take Viread
Danish: Hvis Deres barn har glemt at tage Viread
English: If you notice signs of inflammation or infection, tell your child's doctor at once.
Danish: Hvis De bemærker tegn på betændelse eller infektion, skal De omgående fortælle Deres barns læge det.
English: • Fill the dosing scoop to the top.
Danish: • Fyld måleskeen helt op.
English: Doses of 132 mg, 65 mg and 33 mg tenofovir disoproxil granules once daily are recommended in adult patients with calculated creatinine clearance (CrCl) of 30 to 49 ml/min, 20 to 29 ml/min or 10 to 19 ml/min, respectively.
Danish: Doser på 132 mg, 65 mg og 33 mg tenofovirdisoproxil granulat én gang dagligt anbefales til voksne patienter med en beregnet kreatininclearance (CrCl) på hhv. 30-49 ml/min, 20-29 ml/min og 10-19 ml/min.
English: Subjects must have been naïve to tenofovir disoproxil, with HBV DNA > 105 copies/mL (~ 4.2 log10 IU/mL) and ALT >1.5 × the upper limit of normal (ULN) at screening.
Danish: Forsøgspersonerne skulle være tenofovirdisoproxil-naive, have HBV-dna >105 kopier/ml (~ 4,2 log10 IE/ml) og ALAT >1,5 × den øvre grænse af normalværdien (ULN) ved screening.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu
Danish: De kan finde yderligere oplysninger om Viread på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu.
English: • Contact your doctor before you restart taking Viread granules.
Danish: • Kontakt Deres læge, før De igen begynder at tage Viread granulat.
English: • headache, stomach pain, feeling tired, feeling bloated, flatulence Tests may also show:
Danish: • hovedpine, mavesmerter, træthed, oppustethed, afgang af tarmluft (flatulens) Prøver kan også vise:
English: The benefits of long-term virologic suppression with continued therapy must be weighed against the risk of prolonged treatment, including the emergence of resistant hepatitis B virus and the uncertainties as regards the long term impact of bone and renal toxicity (see section 4.4).
Danish: Fordelene ved langvarig virologisk suppression med fortsat behandling skal opvejes mod risikoen ved langvarig behandling, herunder udvikling af resistent hepatitis b-virus og usikkerhederne i forbindelse med langvarig virkning på knogle- og nyretoksicitet (se pkt.
English: Thirteen percent (6/45) of the tenofovir disoproxil group, 13% (6/45) of the emtricitabine plus tenofovir disoproxil group, and 9% (2/22) of the entecavir group had a confirmed increase in serum creatinine ≥ 0.5 mg/dl or confirmed serum phosphate of < 2 mg/dl.
Danish: 13% (6/45) i tenofovirdisoproxil-gruppen, 13% (6/45) i emtricitabin plus tenofovirdisoproxil-gruppen og 9% (2/22) i entecavir-gruppen havde en bekræftet stigning i serumkreatinin på ≥ 0,5 mg/dl eller bekræftet serumphosphat på < 2 mg/dl.
English: Pharmacokinetic modelling of single-dose pharmacokinetic data in non-HIV and non-HBV infected adult subjects with varying degrees of renal impairment was used to determine dose and dosing interval recommendations for adult subjects with varying degrees of renal impairment (see section 4.2).
Danish: Farmakokinetisk modellering af farmakokinetiske data for enkeltdosis hos voksne forsøgspersoner uden hiv- og HBV-infektion, men med forskellige grader af nedsat nyrefunktion blev anvendt til at fastlægge anbefalinger for dosis og doseringsintervaller for voksne forsøgspersoner med forskellige grader af nedsat nyrefunktion (se pkt.
English: Tell your doctor before taking Viread.
Danish: Tal med Deres læge, før De tager Viread.
English: Experience in patients with compensated liver disease at 48 weeks (studies GS-US-174-0102 and GS-US-174-0103)
Danish: Erfaring hos patienter med kompenseret leversygdom i uge 48 (studie GS-US-174-0102 og GS-US-174-0103)
English: Recommendation concerning co-administration with 245 mg tenofovir disoproxil
Danish: samtidig administration af 245 mg tenofovirdisoproxil
English: Tenofovir disoproxil was associated with significantly greater proportions of patients with undetectable HBV DNA (< 169 copies/ml [< 29 IU/ml]; the limit of quantification of the Roche Cobas Taqman HBV assay), when compared to adefovir dipivoxil (study GS-US-174-0102; 91%, 56% and study GS-US-174-0103; 69%, 9%), respectively.
Danish: Tenofovirdisoproxil var forbundet med signifikant større andele af patienter med HBV-dna, som ikke kunne måles (< 169 kopier/ml [< 29 IE/ml]; kvantificeringsgrænsen for Roche Cobas Taqman HBVanalysen), sammenlignet med adefovirdipivoxil (studie GS-US-174-0102; 91%, 56% henholdsvis studie GS-US-174-0103; 69%, 9%).
English: After 240 weeks of treatment, 117 of 141 subjects (83%) randomised to tenofovir disoproxil had HBV DNA < 400 copies/ml, and 51 of 79 subjects (65%) had ALT normalisation.
Danish: Efter 240 ugers behandling havde 117 ud af 141 forsøgspersoner (83%), der var randomiseret til tenofovirdisoproxil, HBV-dna < 400 kopier/ml, og 51 ud af 79 forsøgspersoner (65%) havde normalisering af ALAT.
English: No amino acid substitutions associated with resistance to tenofovir disoproxil were identified in these isolates by Week 48.
Danish: Der blev ikke identificeret aminosyresubstitutioner forbundet med resistens over for tenofovirdisoproxil i disse isolater ved uge 48.
English: In HIV-1 infected adolescents, the BMD Z-scores observed in subjects who received tenofovir disoproxil were lower than those observed in subjects who received placebo.
Danish: Hos hiv 1-inficerede unge var BMD Z-resultater, der blev observeret hos forsøgspersoner, som fik tenofovirdisoproxil, lavere end de resultater, der blev observeret hos forsøgspersoner, som fik placebo.
English: 0.38 ± 0.13 μg/ml and 3.39 ± 1.22 μg·h/ml, respectively.
Danish: Gennemsnitlig (± SD) Cmax og AUCtau er henholdsvis 0,38 ± 0,13 μg/ml og 3,39 ± 1,22 μg·t/ml.
English: Overall at week 24, treatment with tenofovir disoproxil resulted in 66% (35/53) of patients with HBV DNA < 400 copies/ml (< 69 IU/ml) versus 69% (36/52) of patients treated with emtricitabine plus tenofovir disoproxil (p = 0.672).
Danish: Ved uge 24 var det overordnede resultat, at 66% (35/53) af patienterne behandlet med tenofovirdisoproxil havde HBV-dna < 400 kopier/ml (< 69 IE/ml) versus 69% (36/52) af patienterne behandlet med emtricitabin plus tenofovirdisoproxil (p = 0,672).
English: If you stop taking Viread
Danish: Hvis De holder op med at tage Viread
English: In the tenofovir disoproxil treatment arm, patients had a mean CPT score of 7.2, mean HBV DNA of 5.8 log10 copies/ml and mean serum ALT of 61 U/l at baseline.
Danish: I behandlingsarmen med tenofovirdisoproxil havde patienterne en gennemsnitlig CPT-score på 7,2, en gennemsnitlig HBV-dna på 5,8 log10 kopier/ml og en gennemsnitlig serum-ALAT på 61 E/l ved baseline.
English: Your child can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy.
Danish: mens han/hun tager dette lægemiddel, selvom risikoen er nedsat ved effektiv antiretroviral terapi.
English: The mean baseline CD4 cell count was 279 cells/mm3, the mean baseline plasma HIV-1 RNA was 4.91 log10 copies/ml, 19% of patients had symptomatic HIV-1 infection and 18% had AIDS.
Danish: Det gennemsnitlige CD4-celletal ved baseline var 279 celler/mm3, den gennemsnitlige hiv 1-rna-plasmakoncentration ved baseline var 4,91 log10 kopier/ml, 19% af patienterne havde symptomatisk hiv 1-infektion og 18% havde aids.
English: • Check your child's age and weight to see if Viread 204 mg tablets are suitable, see Children and adolescents.
Danish: • Tjek dit barns alder og vægt for at se, om Viread 204 mg tabletter er egnede, se Børn og unge.
English: 1 tablet each day with food (for example, a meal or a snack).
Danish: 1 tablet en gang dagligt med mad (for eksempel et måltid eller et mellemmåltid).